Article Details

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire

Retrieved on: 2022-07-01 13:47:57

Tags for this article:

Click the tags to see associated articles and topics

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup ... - PR Newswire. View article details on hiswai:

Excerpt

... with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up